-transparent.png){kind=logo}
Beta-2-microglobulin (B2m) serum levels were measured by newly developed electroimmunoassay in a group of patients with inflammatory bowel disease. Increased serum B2m concentrations were found in 66.7% out of 93 subjects with Crohn's disease and in 56.0% out of 25 subjects with idiopathic proctocolitis. According to the author's view, serum B2m can be regarded as a useful adjunct to other immunological markers in diagnostic evaluation and monitoring of Crohn's disease. The high B2m level may reflect elevated biosynthesis and release from immunologically activated lymphocytes in areas of inflammation.
Related Publications
I Krc, and
E Fischerová, and
Z Kojecký, and
L Benýsek, and
I Matousková
August 2014,
World journal of gastroenterology,
I Krc, and
E Fischerová, and
Z Kojecký, and
L Benýsek, and
I Matousková
April 1990,
Acta ophthalmologica,
I Krc, and
E Fischerová, and
Z Kojecký, and
L Benýsek, and
I Matousková
January 1997,
Roczniki Akademii Medycznej w Bialymstoku (1995),
I Krc, and
E Fischerová, and
Z Kojecký, and
L Benýsek, and
I Matousková
January 1991,
Journal of clinical pathology,
I Krc, and
E Fischerová, and
Z Kojecký, and
L Benýsek, and
I Matousková
January 2014,
Clinical laboratory,
I Krc, and
E Fischerová, and
Z Kojecký, and
L Benýsek, and
I Matousková
May 2001,
Scandinavian journal of gastroenterology,
I Krc, and
E Fischerová, and
Z Kojecký, and
L Benýsek, and
I Matousková
November 1990,
Klinische Wochenschrift,
I Krc, and
E Fischerová, and
Z Kojecký, and
L Benýsek, and
I Matousková
January 1987,
The International journal of biological markers,
I Krc, and
E Fischerová, and
Z Kojecký, and
L Benýsek, and
I Matousková
January 1988,
Sbornik vedeckych praci Lekarske fakulty Karlovy university v Hradci Kralove,
I Krc, and
E Fischerová, and
Z Kojecký, and
L Benýsek, and
I Matousková
February 1989,
Acta ophthalmologica,
